David McIntosh: More Than 80% of Patients… Some 200 Million Souls… Receive Little or No Appropriate Treatment
David McIntosh, Founder and Chair of United Plasma Action, reposted David Clement on LinkedIn:
“For all Governments, Patient Representative Groups and others with an interest in plasma-derived medicines but without detailed knowledge, this post is both fascinating and potentially enormously useful.
The subject matter may sound rather academic. It isn’t. It’s a matter of life and death.
Globally, access to plasma-derived medicines is a rare privilige. They are classified as essential medicines, for the treatment of a wide range of rare diseases, but are currently only widely available in rich countries.
In the countries where they are available, these plasma-derived medicines alleviate the suffering of millions and save millions of lives.
Globally, chronic shortages cause untold suffering and widespread loss of life.
More than 80% of patients and undiagnosed sufferers in the World – some 200 million souls – receive little or no appropriate treatment.
The excellent interview here with David Clement is focused on North America. However, its message for the rest of the World is clear also – the way to life-saving national self-sufficiency in these vital medicines is through Voluntary Reasonably Compensated Donation.
Without that eminently effective tool, no country on Earth has ever succeeded in eliminating its medicines shortages in this field.
Globally, as we debate these matters, patients are suffering and dying in heart-rending numbers.
Surely it’s time for the whole World to start listening attentively to David Clement – and implement Voluntary Reasonably Compensated Plasma Donation as an urgent medical and public health priority.”
Quoting David Clement’s post:
“In 2018 I argued that the only way Canada could become more self sufficient for plasma was to pay donors like they do in the U.S. I got an incredible amount of hate. The president of CUPE called me a “shill for big blood” (whatever that means). Tom Korski at Blacklocks grilled me on why I’d push for this. Fast forward to today and CBS has, you guessed it, partnered with Grifols to pay donors for plasma to increase domestic collection. Today I joined Theresa Skubic on Forum Daily to talk all things plasma.”
Read more from David McIntosh on Hemostasis Today.
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS
-
Apr 9, 2026, 21:29Satyam Arora: Improving Thalassaemia Care in India Through Ground-Level Data
-
Apr 9, 2026, 20:33Pat Garcia-Gonzalez: On World Health Day, I’m thinking about what ‘health’ really means
-
Apr 9, 2026, 19:13Jan Sloves: Patterns and Pitfalls Influencing Treatment of Small Saphenous Vein Reflux